Nebraska senators pass cannabis study for seizure sufferers


Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

LINCOLN, Neb. (AP) — Nebraska residents suffering from intractable seizures could have one more treatment option under a medical cannabis study headed to Gov. Pete Ricketts' desk.

Senators voted 44-2 on Thursday to commission a University of Nebraska Medical Center study on the effectiveness of cannabidiol, a cannabis extract, in treating severe epileptic seizures.

Nebraska would obtain cannabidiol from an England-based company authorized by the Federal Drug Administration for rare diseases.

Supporters say the study could provide immediate aid to patients who have exhausted other treatment options.

Ricketts' spokesman says the governor supports FDA-approved studies of marijuana for medical purposes. Ricketts has five days to take action on the bill, sponsored by Sen. Sue Crawford of Bellevue.

__

The bill is LB390

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent U.S. stories

Related topics

U.S.
The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast